![](/img/cover-not-exists.png)
Phase I study of direct administration of a replication deficient adenovirus vector containing vascular endothelial growth factor cDNA (CI-1023) to patients with claudication
S. Rajagopalan, J. Trachtenberg, E. MohlerVolume:
11
Year:
2002
Language:
english
DOI:
10.1016/s1062-1458(02)00972-8
File:
PDF, 35 KB
english, 2002